Montchanin Asset Management’s Pfizer PFE Stock Holding History

Montchanin Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,100	Closed	-$671K	–	50
2022 Q4	$671K	Sell	13,100 -875	-6%	-$42K	0.92%	28
2022 Q3	$612K	Hold	13,975	–	–	0.87%	26
2022 Q2	$733K	Buy	+13,975	New	+$712K	1.01%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Montchanin Asset Management's PFE Position: Q1 2023 in Review

Montchanin Asset Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 13,100 shares — an estimated $671K sold.

Montchanin Asset Management first reported a position in PFE in Q2 2022 and held it in 3 quarters. The position peaked at $733K in Q2 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Montchanin Asset Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Montchanin Asset Management sold 13,100 Pfizer shares in Q1 2023, an estimated $671K.
Montchanin Asset Management first reported a position in Pfizer in Q2 2022 and held it in 3 quarters.
Montchanin Asset Management's Pfizer position peaked at $733K in Q2 2022.
3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Montchanin Asset Management's 13F filing for Q1 2023, filed 10 May 2023.